Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-10

Clinical Trial Update: Ovarian Stimulation With FSH Alone Versus FSH Plus GnRH Antagonist in an Oocyte Donor/Recipient Programme [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial comparing ovarian stimulation with FSH alone versus FSH plus GnRH antagonist in an oocyte donor/recipient program; currently in Phase 1/Phase 2 w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FSH (follicle-stimulating hormone)
  • GnRH antagonist

Snippet

Sponsor: National and Kapodistrian University of Athens | Conditions: Premature Luteinisation, Progesterone Elevation | Phase 1, Phase 2 | Status: UNKNOWN